Comparing Guidelines for the Treatment of Inflammatory Bowel Disease

被引：0

作者：

Hanauer, Stephen B. ^{[1
]}

Kirsner, Joseph B. ^{[1
]}

机构：

[1] Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA

来源：

DIGESTIVE DISEASES | 2013年 / 31卷 / 3-4期

关键词：

CROHNS-DISEASE; EFFICACY; 5-AMINOSALICYLATES; INFLIXIMAB; THERAPY;

D O I：

10.1159/000354695

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

As we enter into the era of 'personalized medicine', many of the recommendations of 'evidence-based medicine' require scrutiny and adaptation to optimize individual outcomes. Several examples of these discrepancies are exemplified by the topics of aminosalicylate use in Crohn's disease, early use of biologic agents that target TNF and the role of calcineurin inhibitors versus anti-TNF agents in steroid-refractory ulcerative colitis. (C) 2013 S.Karger AG, Basel

引用

页码：360 / 362

页数：3

共 50 条

[21] A Review of Four Practice Guidelines of Inflammatory Bowel Disease
Okobi, Okelue E.
Udoete, Iboro O.
Fasehun, Oyinlola O.
Okobi, Tobechukwu
Evbayekha, Endurance O.
Ekabua, Joanna J.
Elukeme, Henry
Ebong, Imoh L.
Ajayi, Olamide O.
Olateju, Iyanu, V
Taiwo, Anthonette
Anaya, Ifeoma C.
Omole, Janet A.
Nkongho, Mireille B.
Ojinnaka, Ugochi
Ajibowo, Abimbola O.
Ogbeifun, Omosefe E.
Ugbo, Osemwegie O.
Okorare, Ovie
Akinsola, Zainab
Olusoji, Rahman A.
Amanze, Ijeoma O.
Nwafor, Jane N.
Ukoha, Nnenna A.
Elimihele, Thomas A.
CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
[22] Quality Assessment of Clinical Practice Guidelines (CPGs) for the Diagnosis and Treatment of Inflammatory Bowel Disease
Hidalgo, Diego
Montesinos-Guevara, Camila
Escobar, Camila
Viteri, Andres
Franco, Juan
Simancas-Racines, Daniel
Hidalgo, Jessica
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S485 - S485
[23] ECCO Guidelines on Extraintestinal Manifestations in Inflammatory Bowel Disease
Gordon, Hannah
Burisch, Johan
Ellul, Pierre
Karmiris, Konstantinos
Katsanos, Konstantinos
Allocca, Mariangela
Bamias, Giorgos
Barreiro-de Acosta, Manuel
Braithwaite, Tasanee
Greuter, Thomas
Harwood, Catherine
Juillerat, Pascal
Lobaton, Triana
Mueller-Ladner, Ulf
Noor, Nurulamin
Pellino, Gianluca
Savarino, Edoardo
Schramm, Christoph
Soriano, Alessandra
Stein, Juergen Michael
Uzzan, Mathieu
van Rheenen, Patrick F.
Vavricka, Stephan R.
Vecchi, Maurizio
Zuily, Stephane
Kucharzik, Torsten
JOURNAL OF CROHNS & COLITIS, 2024, 18 (01): : 1 - 37
[24] Financial Conflicts of Interest in Inflammatory Bowel Disease Guidelines
Grindal, Alexander W.
Khan, Rishad
Scaffidi, Michael A.
Rumman, Amir
Grover, Samir C.
INFLAMMATORY BOWEL DISEASES, 2019, 25 (04) : 642 - 645
[25] Practice guidelines for inflammatory bowel disease: An instrument for assessment
Tremaine, WJ
Sandborn, WJ
MAYO CLINIC PROCEEDINGS, 1999, 74 (05) : 495 - 501
[26] Evaluation of pharmacotherapy recommendations in guidelines for inflammatory bowel disease
Wang, Xiao
Yang, Yan-Min
Yang, Ting
An, Li-Ya
Chen, Xiong-Zhi
Qi, Yu-Xing
He, Hai-Yu
Fan, Hong-Bo
Sun, Da-Li
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2021, 46 (03) : 599 - 609
[27] Assessing the Quality of Inflammatory Bowel Disease (IBD) Guidelines
Askari, Alan
Munasinghe, Aruna
Currie, Andrew
Malietzis, George
Choi, Chang Ho R.
Mortensen, Neil
GASTROENTEROLOGY, 2016, 150 (04) : S792 - S792
[28] Issues in the development of practice guidelines for inflammatory bowel disease
Tremaine, WJ
INFLAMMATORY BOWEL DISEASES, 1997, 3 (04) : 284 - 287
[29] VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE
Haddley, K.
DRUGS OF TODAY, 2014, 50 (04) : 309 - 319
[30] Cannabis for the Treatment of Inflammatory Bowel Disease
Nattali, Timna
Halt, Elizabeth
Yablecovitch, Doron
Konikoff, Fred M.
GASTROENTEROLOGY, 2010, 138 (05) : S699 - S699

← 1 2 3 4 5 →